TELUS Partners with TD Securities and Jefferies to Enhance TELUS Health Strategy and Partnership Opportunities

TELUS Engages TD Securities and Jefferies for Health Division Partnerships

Vancouver, BC – In a notable strategic move, TELUS Corporation has announced the appointment of TD Securities Inc. and Jefferies Securities, Inc. as financial advisors. This decision is part of a broader initiative to enhance the TELUS Health business through strategic partnerships and monetisation strategies. TELUS Health currently reaches over 160 million people globally across more than 200 countries, illustrating its significant impact in the healthcare sector. The division is expected to generate substantial financial returns, with recent figures indicating operating revenue, EBITDA, and cash flow estimated at $1.5 billion, $258 million, and $99 million, respectively, by the end of the third quarter of 2025.

Darren Entwistle, President and CEO of TELUS, emphasized the importance of this partnership with leading financial advisors, stating that their expertise would greatly contribute to the TELUS Health brand's ongoing success and development. As TELUS continues to grow its international presence, the company is determined to leverage its digital health assets effectively, further driving value creation and market expansion.

The engagement with TD Securities and Jefferies aligns with TELUS's commitment to the investment community and its strategy to optimize financial performance. Entwistle highlighted that TELUS Health is not merely a significant asset for the company but one poised for immense growth within the digital health space. The strategy extends beyond mere monetisation—it aims to attract a partner who can introduce complementary skills and enhance customer outreach, thus generating additional economic capacity to spur further growth.

Entwistle also mentioned that this monetisation initiative is part of a larger aim to manage TELUS's financial structure responsibly. The company has a clear vision to reduce its net debt to adjusted EBITDA ratio, targeting a reduction from approximately 3.4 times in 2025 to about 3.0 times by the end of 2027. TELUS's focus on disciplined capital allocation and a robust free cash flow outlook reinforces its objective of creating sustainable value for all stakeholders while adhering to fiscal integrity.

In addition to exploring potential partnerships, this move represents a significant opportunity for TELUS Health to capitalize on rising industry trends and technological advancements. The current climate fosters an environment ripe for collaboration, where TELUS Health intends to expand its diverse service offerings and enhance its contribution to the global healthcare ecosystem.

The announcement serves as a forward-looking statement, indicating TELUS Corporation's proactive stance on future growth and innovation. By engaging reputable financial advisors, TELUS is poised to navigate the complexities of the healthcare market effectively, ensuring that it remains a leader in digital health solutions and technology.

As TELUS embarks on this new chapter, it remains focused on its goals while continuing to provide valuable services to a broad audience. The anticipated benefits of this partnership with TD Securities and Jefferies highlight the commitment of TELUS to maintaining its position at the forefront of healthcare and communications technology, while simultaneously addressing the evolving needs of its clients worldwide. With an enduring focus on community, customers, and technology, TELUS is charting a course towards expanded opportunities and enduring success in the healthcare sector.

For further updates on TELUS Health's progress, industry developments, and strategic partnerships, stay tuned as TELUS navigates this exciting phase in its corporate journey.